Innovative Immunotherapy Approach
Discovered by company cofounder and Nobel Prize winner Ralph Steinman, dendritic cells are like tiny crusaders—patrolling the body to seek out the enemy. Dendritic cells capture, process and identify antigens, or foreign bodies, and then alert the body’s immune response, activating T cells and antibodies to destroy the invaders. Argos’ proprietary Arcelis™ technology approach creates fully personalized immunotherapy to harness and reprogram dendritic cells to target antigens specific to each person’s disease.
View our Arcelis™ Platform or see the Product Pipeline